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Abstract 
Background: Sepsis‑associated acute kidney injury (SA‑AKI) is an independent risk factor for death in patients with 
sepsis, but treatment for it is limited. To improve the diagnosis and treatment of SA‑AKI, we must first understand its 
pathogenesis. Recently, interleukin (IL)‑17A has been shown to be associated with the pathogenesis of acute kidney 
injury and sepsis, but its role in SA‑AKI remains unclear.
Methods: SA‑AKI was induced in male C57BL/6 and IL‑17A−/− mice using cecal ligation and puncture (CLP) opera‑
tions for 24 h.
Results: At 7 days, only seven mice survived in the wild‑type septic group, but nine survived in the IL‑17A−/− septic 
group, corresponding to survival rates of 25 % and 45 %, respectively. At 24 h after CLP operations, both wild‑type 
and IL‑17A−/− septic mice developed kidney injury. The IL‑17A−/− septic mice exhibited decreased serum creatinine 
and blood urea nitrogen levels and an improved acute tubular necrosis score. The IL‑17A−/− septic mice exhibited 
decreased IL‑6, interferon‑γ, tumor necrosis factor‑α, CXCL1, CXCL2, and CXCL5 expression in kidney tissue, but 
increased IL‑10 expression. In addition, renal neutrophil infiltration was attenuated significantly in the IL‑17A−/− septic 
group. Moreover, IL‑17A−/− septic mice showed significantly decreased apoptosis of tubular epithelial cells, including 
decreased TUNEL‑positive tubular cell number and cleaved caspase‑3 level, compared with the wild‑type CLP group. 
Their Bax/Bcl‑2 expression ratio was also increased.
Conclusions: Our study demonstrates that IL‑17A knockout could protect against SA‑AKI. We show that IL‑17A plays 
a pathogenic role in SA‑AKI by increasing the levels of proinflammatory cytokines and chemokines, and by inducing 
neutrophil infiltration and apoptosis of tubular epithelial cells. Accordingly, IL‑17A may be a novel target in SA‑AKI.
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Background
Sepsis-associated acute kidney injury (SA-AKI) is an 
independent risk factor for death in patients with sepsis 
[1], but its treatment is limited. To improve the diagno-
sis and treatment of SA-AKI, we must first understand 
its pathogenesis. In recent years, the majority of stud-
ies on this type of injury have focused on hemody-
namic factors after bacterial invasion. However, in many 
patients, SA-AKI occurs without overt signs of global 
renal hypoperfusion and SA-AKI has been described in 
the presence of normal or even increased renal blood 
flow [2]. Therefore, in recent years, apoptosis, neutro-
phil infiltration, and the production of proinflammatory 
cytokines have been considered important mechanisms 
of SA-AKI [3].
Interleukin (IL)-17 is a proinflammatory cytokine 
secreted mainly by TH17 cells and γδT cells [4]. It consti-
tutes a novel cytokine family that includes six structurally 
related isoforms, IL-17A to IL-17F [5]. IL-17A, the first 
identified member of the IL-17 family, now synonymous 
with IL-17, acts on a variety of cells through its ubiqui-
tous receptors. In addition, it induces the production of 
other cytokines and chemokines from a variety of cells 
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and coordinates the recruitment of myeloid cells, such 
as monocytes and neutrophils, to sites of inflammation 
[6]. The discovery of the IL-17A cytokine family provided 
a novel approach to examine the processes underlying 
inflammatory diseases. It can also help us to identify new 
therapeutic targets of inflammatory diseases.
Although all clinical research on neutralizing a single 
mediator of a single target was unsuccessful, the neu-
tralization of IL-17A still showed promise. Studies have 
reported that IL-17A reached high levels in septic mice 
after cecal ligation and puncture (CLP) injury, and that 
the use of antibodies to neutralize IL-17A improved sep-
sis survival from 10  % to nearly 60  % [7]. Accordingly, 
targeted IL-17A depletion has been adopted as a thera-
peutic strategy and is currently undergoing clinical trials 
for several human autoimmune diseases [8, 9].
Recently, IL-17A has also been shown to be associated 
with the pathogenesis of kidney and intestine ischemia/
reperfusion (I/R) injury [10–12], but its role in SA-AKI 
remains unclear. Thus, in this study, we used IL-17A−/− 
mice to evaluate the role of IL-17A in an SA-AKI model 
induced by CLP injury.
Methods
Animals
Male C57BL/6 mice aged 8–10  weeks were purchased 
from the animal center at The Chinese People’s Libera-
tion Army (PLA) General Hospital (Beijing, China). IL-
17A−/− mice in a C57BL/6 background were kindly 
provided by Professor H. L. Wang (Shanghai Institute 
of Immunology, Institute of Medical Sciences, Shanghai 
Jiao Tong University School of Medicine). The mice were 
maintained on a chow diet in a 12-h light/12-h dark envi-
ronment at 25 °C at The Chinese PLA General Hospital’s 
Animal Care Facility, in accordance with institutional 
guidelines. They were acclimated for 1 week prior to the 
experiments. All animal studies were approved by the 
Ethics Committee of The Chinese PLA General Hospital.
Mouse model of cecal ligation and puncture
Cecal ligation and puncture-induced sepsis was gener-
ated as described previously [13]. Mice were anesthetized 
with 2 % pentobarbital, and a 1- to 2-cm midline incision 
was made along the linea alba of the abdominal muscle to 
isolate and exteriorize the cecum. A total of 75 % of the 
cecum was ligated with a 4-0 silk suture, and the cecum 
was punctured twice with a 21-gauge needle. A small 
amount (droplet) of feces was gently extruded from the 
holes to ensure patency. The cecum was then returned 
to the peritoneal cavity and the abdominal incision was 
closed with 4-0 silk sutures. After the operation, 1  mL 
of pre-warmed normal saline was administered into the 
peritoneal cavity. In the sham group, mice underwent the 
same procedure but were neither ligated nor punctured.
Wild-type and IL-17A−/− mice for blood tests and 
histological and immunochemical analyses were each 
divided into two groups: a sham group and a CLP group. 
Then euthanized 24  h after surgery. Wild-type and IL-
17A−/− mice for survival study were also divided into two 
groups: a sham group and a CLP group. Then euthanized 
7d after surgery (Additional file 1).
Survival study
For a survival study, mice in each group were monitored 
closely for 7 days (n = 20/group), after which they were 
euthanized.
Assessment of kidney function
Kidney injury was assessed based on the levels of serum 
creatinine and blood urea nitrogen. Mouse serum sam-
ples were obtained at 24  h after CLP injury, and the 
serum was separated by centrifugation at 3000  rpm for 
15 min at 4 °C and then stored at −20 °C until use.
Histopathology
For histopathological assessment, kidney tissues were 
harvested 24 h after CLP. Specimens were fixed in 10 % 
formaldehyde for at least 24  h. The samples were then 
embedded in paraffin and sectioned at 4-µm thick-
ness for staining with periodic acid-Schiff. Stained sec-
tions were observed using a light microscope (Olympus 
IX71; Olympus, Tokyo, Japan) at a magnification of 
400× and evaluated by three independent pathologists. 
Histological examinations for acute tubular necrosis 
were semi-quantified and blinded using the following 
scoring system, as described previously [14]: 0 =  none, 
1 = ≤10 %; 2 = 11–25 %, 3 = 26–45 %, 4 = 46–75 %, and 
5 = >75 %.
Real‑time PCR
Total RNA was extracted from kidney tissue using TRI-
zol reagent (Invitrogen, Carlsbad, CA, USA) following 
the manufacturer’s instructions. Reverse transcription 
was performed using the TaqMan Reverse Transcription 
Kit (Applied Biosystems, Foster City, CA, USA) and a 
Gene Amp PCR System 9700 (Applied Biosystems) was 
used to generate cDNA. Real-time quantitative RT-PCR 
using 2  μL of cDNA from each sample was performed 
in duplicate with SYBR Mastermix, in accordance with 
the manufacturer’s instructions. All reactions were per-
formed using a 7500 Real-time PCR System (Applied 
Biosystems). For analysis, glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used as a normalization 
control. The relative target mRNA expression normalized 
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to GAPDH expression was analyzed using the 2−ΔΔCT 
method. The primers used are shown in Table 1.
Immunofluorescence studies of kidney samples
Neutrophil granulocyte infiltration into the kidney was 
evaluated by the detection of Ly6G-positive cells by 
immunofluorescence; Five-µm-thick kidney sections 
were cut and incubated overnight with rat anti-Ly6G 
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
antibody in a humidified chamber. Secondary antibod-
ies conjugated to CY3 rabbit anti-rat immunoglobulin 
G (IgG; 1:50; Jackson ImmunoResearch Laboratories, 
West Grove, PA, USA) were applied for 1 h at room tem-
perature in a darkened humidified chamber. Nuclei were 
stained with 4′,6-diamidino-2-phenylindole (Zhongshan 
Goldenbridge Biotechnology, Beijing, China). Each tissue 
section was observed in a blinded manner under a confo-
cal laser scanning microscope (Olympus FluoView 1000) 
at a magnification of 600×.
TUNEL staining
For terminal deoxynucleotidyl-transferase-mediated 
dUTP nick-end labeling (TUNEL) staining, kidneys were 
fixed in 4  % paraformaldehyde, embedded in paraffin, 
and cut into 5-µm-thick sections and stained using the 
DeadEnd Fluorometric TUNEL system (Promega Corpo-
ration, Madison, WI, USA), in accordance with the man-
ufacturer’s instructions, followed by visualization under 
an Olympus laser scanning confocal microscope (IX81). 
Quantitative analysis of TUNEL-positive cells was per-
formed using the Image-Pro software in 20 random fields 
for each mouse by a technician who was blinded to the 
treatment groups. The mean of all counts was used for 
comparisons among the groups.
Western blot analysis
Kidney lysates were prepared by homogenization on ice 
for 30 min using radioimmunoprecipitation assay buffer 
[50  mM Tris–Cl (pH 7.6), 150  mM NaCl, 1  % NP-40, 
0.1  % sodium dodecyl sulfate, 0.5  % deoxycholic acid, 
1  μg/mL leupeptin, 1  μg/mL aprotinin, and 0.5  mM 
phenylmethylsulfonyl fluoride], and then centrifuged at 
12,000 rpm for 30 min at 4 °C, after which supernatants 
were collected. A total of 100  μg of protein was sepa-
rated by 15 % sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis and transferred to a nitrocellulose mem-
brane. Anti-Bax, -Bcl-2, and -cleaved caspase-3 anti-
bodies (Cell Signaling Technology, Danvers, MA, USA) 
were used as primary antibodies at 4  °C overnight, and 
horseradish peroxidase-conjugated anti-rabbit/mouse 
IgG (Santa Cruz Biotechnology) was used as the second-
ary antibody. Densitometry was performed using Quan-
tity One software (Bio-Rad Laboratories, Hercules, CA, 
USA).
Statistics
The survival of mice was estimated by Kaplan–Meier 
analysis. A log-rank test was used to analyze the survival 
data. Data are expressed as mean ± standard error. Dif-
ferences were evaluated using unpaired Student’s t tests 
between two groups and one-way ANOVA for multiple 
comparisons, followed by a post hoc Student–Newman–
Keuls test when necessary. The value of α was corrected 
by the number of comparisons [2α/n (n − 1)] to ensure 
α = 0.05 [15]. mRNA levels were calculated using the 2−
ΔΔCT method. Analyses were performed using SPSS for 
Windows (version 10.1; SPSS, Chicago, IL, USA). Statisti-
cal significance was set at P < 0.05.
Results
Effect of IL‑17A knockout on the survival of CLP‑induced 
septic mice
In the absence of antibiotic therapy, we investigated 
whether IL-17A−/− septic mice showed any improve-
ment in terms of survival at 7 days. At 24 h, seven mice 
had died in the wild-type CLP group, while only five mice 
had died in the IL-17A−/−-CLP group. At 7 days, the sur-
vival rate of the wild-type septic group was 25 %, while 
that of the knockout IL-17A group was 45 % (Fig. 1). IL-
17A knockout significantly improved the survival rate at 
7 days compared with that in wild-type mice (P < 0.05). 
In addition, no mortality was observed within 7 days in 
all sham mice (survival rate = 100 %).
Effects of IL‑17A knockout on renal function in SA‑AKI
Renal injury was assessed by measuring blood urea 
nitrogen and creatinine levels at 24 h. Baseline levels of 
these plasma markers of kidney injury did not differ sig-
nificantly between the wild-type and IL-17A−/− sham 
groups. Levels of blood urea nitrogen and creatinine 
were increased in wild-type and IL-17A−/− mice with 
Table 1 Primers used for real-time PCR
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CLP-induced sepsis compared with those in the sham 
group, indicative of the development of SA-AKI. Com-
pared with wild-type septic mice, IL-17A−/− septic mice 
showed significantly reduced creatinine and blood urea 
nitrogen levels (P < 0.05; Fig. 2).
Effects of IL‑17A knockout on renal histology in SA‑AKI
Morphological changes in the sepsis group were scored 
24 h after CLP injury based on brush border loss, tubular 
degeneration, and vacuolization in the proximal tubules. 
Knockout of IL-17A ameliorated the tissue damage and 
reduced the tubular injury score (P < 0.05; Fig. 3). Taken 
together, our data show that CLP-induced polymicro-
bial sepsis resulted in SA-AKI, the severity of which was 
reduced by IL-17A knockout.
Effect of IL‑17A knockout on renal cytokine and chemokine 
mRNA levels
Previous studies showed that IL-17A in peritoneal fluid 
plays a critical role during severe polymicrobial sepsis [7]. 
We hypothesized that IL-17A would play an important 
role in SA-AKI. To investigate whether IL-17A knockout 
affected local renal production of inflammatory cytokines 
and chemokines, we assayed the renal mRNA levels of 
these cytokines using RT-PCR. The IL-17A, IL-6, inter-
feron (IFN)-γ, tumor necrosis factor (TNF)-α, and IL-10 
mRNA levels were increased significantly in both CLP 
groups at 24 h (Fig. 4). Compared with the wild-type sep-
tic group, IL-17A knockout decreased the IL-17A, IL-6, 
IFN-γ, and TNF-α mRNA levels (P < 0.05), but increased 
the level of IL-10 (P < 0.05; Fig. 4).
The chemokines CXCL1, CXCL2, and CXCL5 are not 
only potent neutrophil chemoattractants but are also 
encoded by IL-17A target genes. We thus examined the 
mRNA levels of these chemokine genes related to IL-
17A function in the kidney using RT-PCR. The CXCL1, 
CXCL2, and CXCL5 mRNA levels were increased sig-
nificantly in the wild-type CLP group and decreased in 
the IL-17A−/− septic group (P  <  0.05; Fig.  4). SA-AKI 
caused a significant increase in the mRNA levels of all 
five chemokines, consistent with increased neutrophil 
infiltration. Moreover, IL-17A knockout had the oppo-
site effect on the expression of these chemokines after 
SA-AKI.
Effect of IL‑17A knockout on neutrophil infiltration
Neutrophil infiltration is a hallmark of inflammatory 
injury after sepsis [16], and one of the main functions of 
Fig. 1 Survival rate of cecal ligation and puncture (CLP) model mice. Each group consisted of 20 animals. Kaplan–Meier curves show the survival 
rate in each group. The survival rate at 7 days was significantly higher in the interleukin (IL)‑17A knockout CLP group than in the wild‑type CLP 
group; *P < 0.05
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IL-17A is neutrophil recruitment. To determine whether 
neutrophil infiltration played a role in our model, we 
examined the degree of neutrophil infiltration in the 
kidney using immunofluorescence. No Ly-6G-positive 
cell infiltration was detected in the sham group of wild-
type and IL-17A knockout mice (Fig. 5). In the wild-type 
septic group, many Ly-6G-positive cells were observed 
in the renal tissue (Fig. 5), primarily in the renal cortex, 
including the glomerulus and tubulointerstitium. Com-
pared with the wild-type septic group, the IL-17A−/− 
septic group exhibited less neutrophil infiltration 
(Fig. 5).
Fig. 2 Changes in creatinine and blood urea nitrogen in the four groups. IL‑17 knockout significantly reduced creatinine (Cr) and blood urea 
nitrogen (BUN) levels 24 h after CLP injury compared with the levels in wild‑type CLP mice. #P < 0.05 compared with the sham group. *P < 0.05 
compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group n = 20, wild‑type CLP group n = 1 2, and IL‑17A−/− 
septic group n = 15
Fig. 3 Renal histology changes in the four groups. a Sections were subjected to Periodic acid/Schiff staining to assess kidney morphology. b 
Semi‑quantitation of the morphological changes using a histological grading system. The data are presented as mean ± standard deviation (SD). 
#P < 0.05 compared with the sham group. *P < 0.05 compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group 
n = 20, wild‑type CLP group n = 12, and IL‑17A−/− septic group n = 15
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Anti‑apoptotic effects of IL‑17A knockout in SA‑AKI
Apoptosis contributes significantly to AKI. We hypothe-
sized that the role of IL-17A in SA-AKI is associated with 
tubular apoptosis. To test this hypothesis, we performed 
TUNEL assays of renal sections obtained 24 h after CLP 
injury. As shown in Fig. 6, IL-17A knockout significantly 
decreased the number of TUNEL-positive tubular cells 
compared with that in wild-type CLP mice, suggesting 
Fig. 4 mRNA levels of inflammatory cytokines and chemokines in the kidneys. The mRNA levels of the inflammatory cytokines IL‑10, IL‑17, IL‑6, 
interferon‑γ, and tumor necrosis factor‑α and the chemokines CXCL1, CXCL2, and CXCL5 in kidney tissue 24 h after sham or CLP operation. #P < 0.05 
compared with the sham group. *P < 0.05 compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group n = 20, 
wild‑type CLP group n = 12, and IL‑17A−/− septic group n = 15
Fig. 5 Infiltration of neutrophils in the kidneys of the four groups. Histological sections of kidneys were subjected to immunofluorescence staining, 
and the number of positive cells was counted in five high‑powered fields per section (original magnification ×400). Values represent mean ± SD. 
#P < 0.05 compared with the sham group. *P < 0.05 compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group 
n = 20, wild‑type CLP group n = 12, and IL‑17A−/− septic group n = 15
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that IL17A knockout reduced the extent of tubular 
apoptosis.
The expression of cleaved caspase-3, a biomarker of 
apoptosis, was increased significantly in the wild-type 
septic group (Fig.  7). The IL-17A−/− septic group also 
showed an increased cleaved caspase-3 level, albeit sig-
nificantly less than that in the wild-type septic group 
(Fig. 7). Furthermore, Bax expression was increased sig-
nificantly in the wild-type septic group, while there was 
less expression in the kidney of IL-17A−/− septic mice 
at the same time (Fig.  7). In addition, Bcl-2 expression 
decreased slightly in both septic groups. The Bax/Bcl-2 
ratio was increased to a greater extent in the wild-type 
septic group than in the IL-17A−/− septic group. There-
fore, IL-17A knockout attenuated the occurrence of kid-
ney cell death induced by CLP injury.
Discussion
In recent years, research has revealed that the main path-
ogenic factors in SA-AKI are not hemodynamic failure 
or ischemia, as previously thought, but inflammation 
and apoptosis [3]. Accordingly, therapies aimed at sup-
pressing apoptosis and inflammation are currently being 
sought.
In our study, we revealed that IL-17A knockout caused 
a marked amelioration of SA-AKI, which was associated 
with a reduction in neutrophil infiltration and tubular 
cell apoptosis. Moreover, IL-17A enhanced neutrophil 
infiltration, possibly by inducing CXC chemokine-medi-
ated neutrophil migration. In light of these novel find-
ings, IL-17A may become a new therapeutic target.
Increasing evidence has indicated that both adap-
tive and innate immunity play a role in the pathogenesis 
of sepsis [17]. Notably, IL-17A acts as a bridge between 
adaptive and innate immunity through the inflamma-
tory response [18], and thus occupies a unique position 
in the pathogenic process of sepsis. A growing body of 
evidence has also demonstrated that IL-17A is involved 
in the inflammatory response during kidney injury in 
acute renal obstruction [19]. However, little was previ-
ously known about SA-AKI, although IL-17A is involved 
in the pathogenesis of sepsis. In this context, we previ-
ously reported the important finding that circulating IL-
17A levels were elevated in SA-AKI [20]. Therefore, we 
focused on the effect of IL-17A in SA-AKI using the IL-
17A−/− CLP mouse model. Notably, in IL-17A−/− mice, 
kidney function and morphology were found to be pro-
tected after SA-AKI. In this study, genetic deficiency in 
IL-17A ameliorated SA-AKI markedly, as demonstrated 
by reduced mortality, improved inflammatory markers, 
and reduced neutrophil infiltration, which demonstrated 
a critical role for IL-17A in SA-AKI.
Neutrophil recruitment plays a major role in SA-AKI. 
Neutrophil chemotaxis and activation may be regulated 
by CXC chemokines. Interestingly, IL-17A has also been 
shown to induce the production of CXCL1, CXCL2, and 
Fig. 6 Numbers of terminal deoxynucleotidyl‑transferase‑mediated dUTP nick‑end labeling (TUNEL)‑positive cells in the kidneys. Quantitative 
analysis of TUNEL‑positive cells from 20 random fields per mouse. The data are presented as mean ± SD. #P < 0.05 compared with the sham group. 
*P < 0.05 compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group n = 20, wild‑type CLP group n = 12, and 
IL‑17A−/− septic group n = 15
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CXCL5 in mouse osteoblastic cells and lung fibroblasts 
[21, 22]. Moreover, IL-17A has been shown to induce 
the recruitment of neutrophils into the airways via the 
production of CXC chemokines [23]. However, the pro-
duction of IL-17A during infection has not always been 
correlated with protection. In a murine CLP model 
of polymicrobial sepsis, IL-17A from γδT cells was 
detected, but its depletion led to a decrease in bacteremia 
and reductions in systemic proinflammatory cytokines 
(TNF-α, IL-1β, and IL-6) and chemokines [24]. In our 
study, we found that the inhibition of IL-17A markedly 
decreased renal CXCL1, CXCL2, and CXCL5 expression 
and neutrophil infiltration. This is consistent with pre-
vious reports describing that elevated IL-17A induced 
neutrophil recruitment and increased inflammation in a 
more severe CLP model [7]. IL-17A also enhanced cardi-
omyocyte LIX, KC, and MIP-2 production and neutrophil 
migration to the supernatant from conditioned car-
diomyocytes in  vitro [25]. Although we have no further 
data to validate the pathogenic role of IL-17A in SA-AKI 
in vitro, which is a limitation of our study, our results still 
indicate that IL-17A may contribute to SA-AKI, at least 
in part through the regulation of neutrophil infiltration to 
the kidney by affecting CXC chemokine expression.
Apoptosis plays an important role in health and dis-
ease. It also contributes to kidney dysfunction in I/R or 
nephrotoxin-induced AKI [26, 27]. However, no consen-
sus has been reached on the role of renal cell apoptosis in 
the development of SA-AKI. In terms of the histopatho-
logical findings from biopsies taken from septic AKI 
patients, these have been reported to include acute 
tubular injury or necrosis to varying degrees; leukocyte 
infiltration into glomeruli, interstitial capillaries, and 
tubular lumen; and apoptosis in tubular cells and on rare 
occasions in glomerular cells [28, 29]. In contrast, Lan-
genberg et  al. [30] reported a lack of any tubular injury 
or apoptosis in a sheep SA-AKI model. However, in our 
study, we observed that a substantial number of tubular 
cells underwent apoptosis. In addition to increased num-
bers of TUNEL-positive cells, cleaved caspase-3 activity 
and Bax were also increased in septic kidneys compared 
with those in sham kidneys. Meanwhile, the reduced 
level of the anti-apoptosis protein Bcl-2 also suggested 
that apoptosis occurred in the kidneys of septic mice 
Fig. 7 Expression of Bax, Bcl‑2, and cleaved caspase‑3 in the kidneys. a Western blot results for cleaved caspase‑3 protein. b Quantitative analysis of 
cleaved caspase‑3. c Western blot of Bax and Bcl‑2 proteins. d Quantitative analysis of Bax and Bcl‑2. The protein levels are presented as mean ± SD. 
#P < 0.05 compared with the sham group. *P < 0.05 compared with the wild‑type CLP group. Wild‑type sham group n = 20, IL‑17A−/− sham group 
n = 20, wild‑type CLP group n = 12, and IL‑17A−/− septic group n = 15
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after CLP surgery. IL-17A has also been shown to induce 
apoptosis of vascular smooth muscle cells and airway 
epithelial cells [31, 32]. However, there are no reports 
on the role of IL-17A in renal tubular cell apoptosis. 
Our in vivo study showed that IL-17A knockout reduced 
tubular cell apoptosis, as confirmed by the decreased 
number of TUNEL-positive tubular cells, the reduced 
cleaved caspase-3 activity, and the ratio of pro-apoptotic 
(Bax) to anti-apoptotic (Bcl-2) proteins. IL-17A may trig-
ger apoptosis directly in tubular cells or indirectly by 
mediating the production of other factors. However, the 
regulation of cleaved caspase-3 activity and the Bax/Bcl-2 
ratio demonstrated that IL-17A activated intrinsic signal-
ing pathways. These findings indicate that IL-17A plays 
a pathogenic role in SA-AKI by inducing apoptosis and 
neutrophil infiltration (Additional file 1).
There are some limitations to this study. A previous 
study reported that SA-AKI does not result from hypop-
erfusion alone, but may arise to a large extent from renal 
inflammation and tubular responses to various sepsis 
mediators. In many patients, SA-AKI occurs without 
overt signs of global renal hypoperfusion and SA-AKI 
has been described in the presence of normal or even 
increased renal blood flow [33]. Therefore, in our study, 
we did not perform hemodynamic monitoring, which 
was one of the limitations. Another previous study also 
reported that the neutralization of peritoneal IL-17A 
markedly improves lung injury in severe CLP-induced 
septic mice [7]. Although we did not prove a beneficial 
effect of blocking IL-17A in other organ systems in this 
study, based on the above data, we believe that the ben-
eficial effect of blocking IL-17A could be mediated by 
other organ systems as well as AKI. Moreover, although 
we observed decreased levels of IL-17A-related cytokines 
and chemokines in renal tissues after IL-17A knockout, 
the mechanism by which IL-17A knockout could pro-
tect against SA-AKI remains unclear. It is also needs to 
be determined whether the improved renal apoptosis is 
directly related to the knockout of IL-17A.
Conclusions
Overall, our study demonstrated that IL-17A knockout 
could protect against SA-AKI. We showed that IL-17A 
may play a pathogenic role in SA-AKI by increasing the 
levels of proinflammatory cytokines and chemokines, 
and reducing neutrophil infiltration and apoptosis of 
tubular epithelial cells. Accordingly, IL-17A may be a 
novel target in the treatment of SA-AKI.
Additional file
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